Patents/Assignees

Pfizer Inc.

150 patents in portfolio

US12404315utility2025
Protease-activating Cd45-gate CAR
0 cites
US12398119utility2025
Piperazine Azaspiro Derivatives
0 cites
US12383611utility2025
Neisseria Meningitidis Compositions and Methods Thereof
0 cites
US12384764utility2025
Pharmaceutical Compounds
0 cites
US12378232utility2025
Cyclin Dependent Kinase Inhibitors
0 cites
US12378230utility2025
GLP-1 Receptor Agonists and Uses Thereof
0 cites
US12371499utility2025
Method of Treating Cancer Using Anti-av8 Antibodies
0 cites
US12364749utility2025
RSV F Protein Mutants
0 cites
US12357681utility2025
E. Coli Fimh Mutants and Uses Thereof
0 cites
US12358897utility2025
Compounds and Method of Treating COVID-19
0 cites
US12343389utility2025
Streptococcus Pneumoniae Capsular Polysaccharides and Conjugates Thereof
0 cites
US12331041utility2025
GLP-1 Receptor Agonists and Uses Thereof
0 cites
US12318438utility2025
Immunogenic Compositions for Use in Pneumococcal Vaccines
0 cites
US12319669utility2025
GLP-1 Receptor Agonists and Uses Thereof
0 cites
US12312344utility2025
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides Useful as CCR6 Inhibitors
0 cites
US12312358utility2025
Crystalline Pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone Compound and Use Thereof
0 cites
US12303509utility2025
Compounds for the Treatment of Braf-associated Diseases and Disorders
0 cites
US12297177utility2025
Solid State Forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide and Uses Thereof
0 cites
US12296012utility2025
Chimeric Antigen Receptors Targeting FLT3
0 cites
US12297190utility2025
Modulators of STING (stimulator of Interferon Genes)
0 cites

← PreviousPage 2 of 8Next →